Patent Assignment
Reel/Frame 019920/0366
Merger
Recorded: 2007-10-05
Pages: 8
Assignor
ICN PHARMACEUTICALS INC.
Executed: 2003-11-10
Assignee
VALEANT PHARMACEUTICALS INTERNATIONAL
3300 HYLAND AVENUE, COSTA MESA, CALIFORNIA, 92626
Covered Property
(1)
Conformationally Constrained L-Nucleosides
Patent:
6,525,191 →
Application:
09/569,183 →
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 13, 2007
From: VALEANT PHARMACEUTICALS INTERNATIONAL
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 019424/0836 →
Security Agreement
Oct 4, 2010
From: ATON PHARMA, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA; VALEANT PHARMACEUTICALS INTERNATIONAL; CORIA LABORATORIES, LTD.
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 025084/0169 →
Patent Security Release Agreement
Mar 14, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS NORTH AMERICA; CORIA LABORATORIES, LTD.; DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 025950/0048 →
Change of Name
Jul 26, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 043349/0673 →